A 75-year-old man with basilar artery occlusion underwent successful rescue treatment using Tigertriever-assisted stent retriever angioplasty, according to a case report published in Cureus.
The procedure was performed after initial mechanical thrombectomy failed to restore blood flow to the brain.
The patient, who had a history of diabetes and hypertension, arrived at the hospital with fluctuating weakness and dysarthria. Magnetic resonance angiography confirmed the basilar artery was blocked. Mechanical thrombectomy failed, leading surgeons to attempt a stepwise approach using the Tigertriever device, which allows for manual control of mesh expansion and radial force.
Managing Basilar Artery Occlusion
Doctors administered dual antiplatelet therapy consisting of 200 mg of aspirin and 20 mg of prasugrel via a nasogastric tube to prevent re-occlusion during the procedure. Stable reperfusion was achieved 30 minutes after the antiplatelet drugs were given, leaving roughly 70% residual stenosis. The patient was discharged on postprocedural day 11 with a modified Rankin Scale score of 1, indicating minimal disability.
A separate case reported by the Japanese Society for Neuroendovascular Therapy involved an 80-year-old woman who suffered a basilar artery occlusion complicated by tandem lesions in the vertebral artery. Surgeons there also utilized a stent retriever and combined antithrombotic therapy after a balloon catheter failed to navigate the vessel due to tortuosity.
Risks of Intracranial Atherosclerotic Disease
The optimal endovascular strategy for large vessel occlusions linked to intracranial atherosclerotic disease remains uncertain. Standard mechanical thrombectomy, while effective for cardioembolic strokes, often faces limitations when the underlying cause is plaque buildup. Balloon angioplasty carries the risk of displacing plaque into smaller perforating arteries, which can cause brainstem infarction, while permanent stenting may trigger endothelial injury.
The Tigertriever offers a potential alternative because it can be collapsed in situ, reducing friction against vessel walls. "The ability to fully collapse the Tigertriever in situ may reduce friction against the vessel wall during repositioning and retrieval, potentially minimizing endothelial injury," the authors noted in Cureus.
Two Patients Show Improved Outcomes After Procedure
| Patient | Age | Initial NIHSS Score | Final Status |
|---|---|---|---|
| Male Patient | 75 | 4 (rising to 11) | mRS 1 at 11 days |
| Female Patient | 80 | 28 | Improved consciousness |
The 75-year-old patient showed sustained patency of the basilar artery 16 months after the procedure. Despite these results, researchers emphasize that the safety and efficacy of this non-stenting rescue strategy cannot be established from individual cases alone. Further studies are required to determine standard antiplatelet regimens and long-term outcomes for patients with atherosclerotic basilar artery occlusion.
Questions Regarding Endovascular Treatment
Why is treating basilar artery occlusion considered high-risk?
The basilar artery provides blood to critical brainstem structures via numerous small perforating arteries. Any procedure that risks plaque displacement or vessel injury can lead to severe neurological deficits or brainstem infarction.
What distinguishes Tigertriever from standard stent retrievers?
The device features a unique mechanism that allows for manual adjustment of mesh expansion and precise control of radial force, which provides a balance between luminal dilation and safety.
What are the primary challenges in treating atherosclerotic LVO?
Maintaining long-term recanalization is difficult because the underlying plaque often causes recoil or re-occlusion. Additionally, tandem lesions—stenosis occurring in both the intracranial and extracranial vessels—can make it challenging for surgeons to navigate catheters to the site of the blockage.
Keep reading